Press release
Preclinical Oncology Models Market Deep Research Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Preclinical Oncology Models Market- By Product Type (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model) - Global Forecast to 2030" The report features detailed industry analysis and extensive insights on the market, exploring its significant growth factors.
According to the latest market intelligence research report by InsightAce Analytic, the global preclinical oncology models market size was valued at US$ 1,020.2 Million in 2021, and it is expected to reach US$ 2,463.7 Million in 2030, recording a promising CAGR of 10.6% from 2022 to 2030.
Request Sample Report:
https://www.insightaceanalytic.com/request-sample/1093
Scientists require preclinical oncology models to predict the clinical efficacy of novel anticancer drugs. The increased demand for cancer immunotherapy has spawned numerous preclinical and translational obstacles. Therefore, there is an excellent need for preclinical models to screen anticancer agents with solid clinical correlation accurately.
Advances in immuno-oncology, increasing targeted and novel cancer therapies, rising R&D activities in oncology and drug development, high demand for robust preclinical oncology models such as humanized and syngeneic tumour models, and the rising need to reduce translational failures in clinical trials are anticipated to drive market growth during the forecast period. In addition, the need for the rational design of combination therapies and the early identification of predictive biomarkers also contribute to expanding the preclinical oncology models market.
Inquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1093
The prominent players in the preclinical oncology models industry include:
Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc, Pharmatest Services, Taconic Biosciences, Inc., The Jackson Laboratory, and Other Prominent Players.
Key Industry Developments from Leading Players:
• In Dec 2021, Crown Bioscience, a leading contract research organization (CRO) in preclinical and translational drug development services, expanded its Crown Bioscience United Kingdom facility. This expansion offers additional imaging modalities to visualize better and understand tumor progression and response to potential therapies. The additional imaging platform allows performing cutting-edge preclinical studies, offering advanced insights on potential drug candidates before clinical trials.
• In Feb 2021, Charles River Laboratories International, Inc. partnered with Kibur Medical to provide exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies.
• In May 2020, BioDuro, LLC, a leading drug discovery and development services organization, announced the availability of two new preclinical models for Non-alcoholic steatohepatitis (NASH) that highly resemble the clinical progression of the disease. The models include mouse and hamster species and manifest all the hallmarks of NASH disease, enabling drug developers to evaluate broad classes of drug targets, including metabolic inflammation and fibrogenic pathways alike.
Preclinical Oncology Models Market Regional Analysis:
North America is expected to be the most lucrative region of this market in the forecast years, owing to the high demand for cancer immunotherapies, increasing research funding for oncology, and the need for preclinical oncology models.
The Asia Pacific is estimated to proliferate during the analysis of the forecast period. The technological advancement in cancer diagnostic techniques & treatment, high demand for targeted therapies, and the increasing R&D initiatives in oncology clinical trials by industry players are the factors responsible for the regional market growth.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1093
The Global Preclinical Oncology Models Market Segments
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Application
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada
Europe Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-preclinical-oncology-models-market/1093
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
According to the latest market intelligence research report by InsightAce Analytic, the global preclinical oncology models market size was valued at US$ 1,020.2 Million in 2021, and it is expected to reach US$ 2,463.7 Million in 2030, recording a promising CAGR of 10.6% from 2022 to 2030.
Request Sample Report:
https://www.insightaceanalytic.com/request-sample/1093
Scientists require preclinical oncology models to predict the clinical efficacy of novel anticancer drugs. The increased demand for cancer immunotherapy has spawned numerous preclinical and translational obstacles. Therefore, there is an excellent need for preclinical models to screen anticancer agents with solid clinical correlation accurately.
Advances in immuno-oncology, increasing targeted and novel cancer therapies, rising R&D activities in oncology and drug development, high demand for robust preclinical oncology models such as humanized and syngeneic tumour models, and the rising need to reduce translational failures in clinical trials are anticipated to drive market growth during the forecast period. In addition, the need for the rational design of combination therapies and the early identification of predictive biomarkers also contribute to expanding the preclinical oncology models market.
Inquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1093
The prominent players in the preclinical oncology models industry include:
Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc, Pharmatest Services, Taconic Biosciences, Inc., The Jackson Laboratory, and Other Prominent Players.
Key Industry Developments from Leading Players:
• In Dec 2021, Crown Bioscience, a leading contract research organization (CRO) in preclinical and translational drug development services, expanded its Crown Bioscience United Kingdom facility. This expansion offers additional imaging modalities to visualize better and understand tumor progression and response to potential therapies. The additional imaging platform allows performing cutting-edge preclinical studies, offering advanced insights on potential drug candidates before clinical trials.
• In Feb 2021, Charles River Laboratories International, Inc. partnered with Kibur Medical to provide exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies.
• In May 2020, BioDuro, LLC, a leading drug discovery and development services organization, announced the availability of two new preclinical models for Non-alcoholic steatohepatitis (NASH) that highly resemble the clinical progression of the disease. The models include mouse and hamster species and manifest all the hallmarks of NASH disease, enabling drug developers to evaluate broad classes of drug targets, including metabolic inflammation and fibrogenic pathways alike.
Preclinical Oncology Models Market Regional Analysis:
North America is expected to be the most lucrative region of this market in the forecast years, owing to the high demand for cancer immunotherapies, increasing research funding for oncology, and the need for preclinical oncology models.
The Asia Pacific is estimated to proliferate during the analysis of the forecast period. The technological advancement in cancer diagnostic techniques & treatment, high demand for targeted therapies, and the increasing R&D initiatives in oncology clinical trials by industry players are the factors responsible for the regional market growth.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1093
The Global Preclinical Oncology Models Market Segments
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Application
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
The Global Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada
Europe Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-preclinical-oncology-models-market/1093
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
